GSK Says Boehringer Spreading Lies About Its Inhalers
Pharmaceutical company GlaxoSmithKline LLC on Tuesday accused rival Boehringer Ingelheim Pharmaceuticals Inc. of spreading false and misleading information about GSK inhalers for patients with chronic obstructive pulmonary disease, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article